Literature DB >> 19278963

Molecular allelokaryotyping of T-cell prolymphocytic leukemia cells with high density single nucleotide polymorphism arrays identifies novel common genomic lesions and acquired uniparental disomy.

Daniel Nowak1, Emilie Le Toriellec, Marc-Henri Stern, Norihiko Kawamata, Tadayuki Akagi, Martin J Dyer, Wolf-Karsten Hofmann, Seishi Ogawa, H Phillip Koeffler.   

Abstract

BACKGROUND: T-cell prolymphocytic leukemia is a rare aggressive lymphoproliferative disease with a mature T-cell phenotype and characteristic genomic lesions such as inv(14)(q11q34), t(14;14)(q11;q32) or t(X;14)(q28;q11), mutation of the ATM gene on chromosome 11 and secondary alterations such as deletions of chromosome 8p and duplications of 8q. DESIGN AND METHODS: We analyzed malignant cells from 18 patients with T-cell prolymphocytic leukemia using high density 250K single nucleotide polymorphism arrays and molecular allelokaryotyping to refine understanding of known alterations and identify new target genes.
RESULTS: Our analyses revealed that characteristic disruptions of chromosome 14 are frequently unbalanced. In the commonly deleted region on chromosome 11, we found recurrent microdeletions targeting the microRNA 34b/c and the transcription factors ETS1 and FLI1. On chromosome 8, we identified genes such as PLEKHA2, NBS1, NOV and MYST3 to be involved in breakpoints. New recurrent alterations were identified on chromosomes 5p, 12p, 13q, 17 and 22 with a common region of acquired uniparental disomy in four samples on chromosome 17q. Single nucleotide polymorphism array results were confirmed by direct sequencing and quantitative real-time polymerase chain reaction.
CONCLUSIONS: The first high density single nucleotide polymorphism array allelokaryotyping of T-cell prolymphocytic leukemia genomes added substantial new details about established alterations in this disease and moreover identified numerous new potential target genes in common breakpoints, deletions and regions of acquired uniparental disomy.

Entities:  

Mesh:

Year:  2009        PMID: 19278963      PMCID: PMC2663615          DOI: 10.3324/haematol.2008.001347

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  48 in total

Review 1.  The role of Fli-1 in normal cell function and malignant transformation.

Authors:  A H Truong; Y Ben-David
Journal:  Oncogene       Date:  2000-12-18       Impact factor: 9.867

2.  Recurrent ATM mutations in T-PLL on diverse haplotypes: no support for their germline origin.

Authors:  T Stankovic; A M Taylor; M R Yuille; I Vorechovsky
Journal:  Blood       Date:  2001-03-01       Impact factor: 22.113

3.  Unusual breakpoint distribution of 8p abnormalities in T-prolymphocytic leukemia: a study with YACS mapping to 8p11-p12.

Authors:  A Sorour; V Brito-Babapulle; D Smedley; M Yuille; D Catovsky
Journal:  Cancer Genet Cytogenet       Date:  2000-09

Review 4.  Molecular basis of mature T-cell leukemia.

Authors:  Y Pekarsky; C Hallas; C M Croce
Journal:  JAMA       Date:  2001-11-14       Impact factor: 56.272

5.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

6.  A complex pattern of recurrent chromosomal losses and gains in T-cell prolymphocytic leukemia.

Authors:  J Soulier; G Pierron; D Vecchione; R Garand; F Brizard; F Sigaux; M H Stern; A Aurias
Journal:  Genes Chromosomes Cancer       Date:  2001-07       Impact factor: 5.006

Review 7.  Mechanisms leading to uniparental disomy and their clinical consequences.

Authors:  W P Robinson
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

Review 8.  The TCL1 family of oncoproteins: co-activators of transformation.

Authors:  Michael A Teitell
Journal:  Nat Rev Cancer       Date:  2005-08       Impact factor: 60.716

9.  High remission rate in T-cell prolymphocytic leukemia with CAMPATH-1H.

Authors:  C E Dearden; E Matutes; B Cazin; G E Tjønnfjord; A Parreira; B Nomdedeu; P Leoni; F J Clark; D Radia; S M Rassam; T Roques; N Ketterer; V Brito-Babapulle; M J Dyer; D Catovsky
Journal:  Blood       Date:  2001-09-15       Impact factor: 22.113

10.  Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed.

Authors:  M J Keating; B Cazin; S Coutré; R Birhiray; T Kovacsovics; W Langer; B Leber; T Maughan; K Rai; G Tjønnfjord; M Bekradda; M Itzhaki; P Hérait
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

View more
  13 in total

1.  Genome-wide Mapping of Copy Number Variations Using SNP Arrays.

Authors:  Daniel Nowak; Wolf-Karsten Hofmann; H Phillip Koeffler
Journal:  Transfus Med Hemother       Date:  2009-07-10       Impact factor: 3.747

Review 2.  Mature T-cell leukemias: Molecular and Clinical Aspects.

Authors:  Nathanael G Bailey; Kojo S J Elenitoba-Johnson
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

3.  Genomic profiling of adult acute lymphoblastic leukemia by single nucleotide polymorphism oligonucleotide microarray and comparison to pediatric acute lymphoblastic leukemia.

Authors:  Ryoko Okamoto; Seishi Ogawa; Daniel Nowak; Norihiko Kawamata; Tadayuki Akagi; Motohiro Kato; Masashi Sanada; Tamara Weiss; Claudia Haferlach; Martin Dugas; Christian Ruckert; Torsten Haferlach; H Phillip Koeffler
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

4.  Redundant and nonredundant functions of ATM and H2AX in αβ T-lineage lymphocytes.

Authors:  Bu Yin; Baeck-Seung Lee; Katherine S Yang-Iott; Barry P Sleckman; Craig H Bassing
Journal:  J Immunol       Date:  2012-06-22       Impact factor: 5.422

5.  Molecular characterization of EZH2 mutant patients with myelodysplastic/myeloproliferative neoplasms.

Authors:  J Rinke; J P Müller; M F Blaess; A Chase; M Meggendorfer; V Schäfer; N Winkelmann; C Haferlach; N C P Cross; A Hochhaus; T Ernst
Journal:  Leukemia       Date:  2017-06-19       Impact factor: 11.528

6.  Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.

Authors:  Mark J Kiel; Thirunavukkarasu Velusamy; Delphine Rolland; Anagh A Sahasrabuddhe; Fuzon Chung; Nathanael G Bailey; Alexandra Schrader; Bo Li; Jun Z Li; Ayse B Ozel; Bryan L Betz; Roberto N Miranda; L Jeffrey Medeiros; Lili Zhao; Marco Herling; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  Blood       Date:  2014-05-13       Impact factor: 22.113

7.  SNP array analysis of tyrosine kinase inhibitor-resistant chronic myeloid leukemia identifies heterogeneous secondary genomic alterations.

Authors:  Daniel Nowak; Seishi Ogawa; Markus Müschen; Motohiro Kato; Norihiko Kawamata; Antonie Meixel; Verena Nowak; Han S Kim; Sharon Kang; Ronald Paquette; Mi-Sook Chang; Nils H Thoennissen; Nils H Thoenissen; Max Mossner; Wolf-Karsten Hofmann; Alexander Kohlmann; Tamara Weiss; Torsten Haferlach; Claudia Haferlach; H Phillip Koeffler
Journal:  Blood       Date:  2009-12-02       Impact factor: 22.113

8.  Do novo del(9)(p13) in a childhood T-cell prolymphocytic leukemia as sole abnormality.

Authors:  Abdulsamad Wafa; Abdulmunim Aljapawe; Moneeb Ak Othman; Thomas Liehr; Eyad Alhourani; Walid Al Achkar
Journal:  Exp Hematol Oncol       Date:  2014-11-25

Review 9.  SNP Array in Hematopoietic Neoplasms: A Review.

Authors:  Jinming Song; Haipeng Shao
Journal:  Microarrays (Basel)       Date:  2015-12-22

10.  "T-cell prolymphocytic leukemia (T-PLL), a heterogeneous disease exemplified by two cases and the important role of cytogenetics: a multidisciplinary approach".

Authors:  Carlos A Tirado; Phillip Starshak; Paul Delgado; Nagesh Rao
Journal:  Exp Hematol Oncol       Date:  2012-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.